Alert
Close

Help hungry seniors. Deliver help and hope before Thanksgiving. Donate

HIGHLIGHTS

Open

AARP VETERAN MEMBERSHIP

Military and Veterans Discount

CONTESTS AND SWEEPS

AARP REALPAD

Introducing RealPad by AARP

AUTO BUYING PROGRAM

AARP Auto Buying Program

DRIVER SAFETY

Piggy bank on the road - AARP Driver Safety

Take the new AARP Smart Driver Course!

Download the ipad App

AARP-iPad-ePub-app

KEEP BRAIN ACTIVE!

AARP Games - Play Now!

Learning Centers

Get smart strategies for managing health conditions.


Arthritis

Heart Disease

Diabetes

Most Popular

Viewed

Health Discovery

Vitamin A May Be Key to Better Breast Cancer Drugs

Generic Drugs in Bottles

— Getty Images/Comstock Images

STUDY FINDINGS:

A form of retinoic acid, a vitamin A derivative, could lead to a new drug combination for breast cancer treatment.


A recent study from the University of Chicago may lead to new treatments for common breast cancers that don’t respond to traditional therapies. Using cells taken from patients with estrogen-related breast cancers, researchers at the Institute for Genomics and System Biology compared how the receptors of estrogen and retinoic acid, a derivative of vitamin A, affected the genes involved in breast cancer. (Receptors, often described as the ears or antennae on a cell, can send signals for breast cancer cells to grow.)

The results, reported in the June 26 issue of the journal Cell, found that the estrogen receptor and the retinoic acid receptor appeared to compete with each other to activate or repress many of the same genes, according to Kevin White, director of the institute and one of the study’s authors. “What we found was not only that these receptors target many of the same breast cancer genes, but also that they have an antagonistic relationship,” he says. Estrogen can send signals that tell breast cancer cells to grow, while retinoic acid seems to inhibit cellular growth. “We call it a yin yang effect,” White says.

Retinoic acid has been approved for the treatment of promyelocytic leukemia, but it can be quite toxic. The goal is to develop a retinoic acid derivative with similar structure and function but with a much lower toxicity that could be used in combination with standard drugs like tamoxifen, or to develop new anticancer drugs. “These studies suggest that combining drugs that target the retinoic acid pathway with those targeting the estrogen receptor pathway might prove more fruitful in treatment of breast cancer,” says Harold Burstein, M.D., a breast cancer specialist at the Dana-Farber Cancer Institute in Boston.


Cathie Gandel is a freelance writer who covers health and science.

Topic Alerts

You can get weekly email alerts on the topics below. Just click “Follow.”

Manage Alerts

Processing

Please wait...

progress bar, please wait

Tell Us WhatYou Think

Please leave your comment below.

Discounts & Benefits

From companies that meet the high standards of service and quality set by AARP.

Membership Discount Benefit Pet Plan Dog

Members save 10% or more on Petplan pet insurance premiums.

Senior couple working on laptop. Medicare open enrollment. (David Jakle/Corbis)

Medicare Open Enrollment Period Ends Dec. 7 ─ AARP® Medicare Plans from UnitedHealthcare.

Grandson (8-9) whispering to grandfather, close-up

Members can save 20% on hearing aids with the AARP® Hearing Care Program provided by HearUSA.

Member Benefits

Join or renew today! AARP members receive exclusive member benefits & affect social change.

Rewards for Good

Your Points Balance:

Learn More

Earn points for completing free online activities designed to enrich your life.

Find more ways to earn points

Redeem your points to save on merchandise, travel, and more.

Find more ways to redeem points